UPDATE : Friday, September 20, 2019
상단여백
Market caps of top 20 drugmakers on KOSPI surged this year
Market capitalizations of high-ranking pharmaceutical and biotech companies...
by Nam Doo-hyun  |  2018-11-06 15:41
라인
Samsung BioLogics to complete Biogen’s call option
Samsung BioLogics posted Tuesday that the transfer of assets related to Sam...
by Lee Han-soo  |  2018-11-06 10:45
라인
Will PharmAbcine be new force on KOSDAQ?
PharmAbcine, an immuno-oncology company, might be a promising biotech firm ...
by Nam Doo-hyun  |  2018-11-05 16:32
라인
Celltrion gets orders for Herzuma in France
Celltrion Healthcare, a subsidiary of Celltrion, said Friday that it has su...
by Lee Han-soo  |  2018-11-02 17:08
라인
Government to help Pharmicell develop therapy for acute kidney injury
Pharmicell said Friday that the Ministry of Health and Welfare has decided ...
by Lee Han-soo  |  2018-11-02 14:16
라인
SLS Bio registers patent for nanotechnology multiplex diagnostic in Europe
SLS Bio said it has registered a patent related to its nanotechnology multi...
by Lee Han-soo  |  2018-11-01 11:03
라인
CrystalGenomics to change molecular targeted therapy from injection to oral drug in trials
CrystalGenomics said it would change the form of an investigational molecul...
by Nam Doo-hyun  |  2018-10-30 10:52
라인
‘I will help make Korea original holder of anticancer drugs’
“Original technologies are important for national development. We will deve...
by So Jae-hyeon  |  2018-10-29 14:43
라인
‘Bio Solution’s value to rise on arthritis cell therapy’
Bio Solution will be able to drive up its market capitalization once it obt...
by Nam Doo-hyun  |  2018-10-25 16:30
라인
Samsung BioLogics posts ₩101.1 billion in Q3 sales
Samsung BioLogics said Wednesday that it recorded 101.1 billion won ($88.7 ...
by Lee Han-soo  |  2018-10-25 11:02
라인
CancerRop advances into Malaysian gene market
CancerRop said Wednesday that it has signed a cooperative agreement with Ca...
by Lee Han-soo  |  2018-10-24 17:49
라인
Celltrion releases clinical trial results for Remsima SC in EU and US
Celltrion has presented phase 1 and 3 clinical trials for Remsima SC, the s...
by Lee Han-soo  |  2018-10-24 16:47
라인
Will synthetic biology be vital in smart therapeutics?
Synthetic biology, which designs biological components and systems in new w...
by Nam Doo-hyun  |  2018-10-24 16:40
라인
Biotech shares tank amid nosediving of Seoul stocks
Biotech and pharmaceutical shares plunged on Tuesday, hurt mainly by the ov...
by Nam Doo-hyun  |  2018-10-24 11:35
라인
‘Antibody drug developer AbClon noteworthy’
AbClon, a developer of innovative antibody medicines, is likely to achieve ...
by Nam Doo-hyun  |  2018-10-22 14:49
라인
L&C BIO sets offering price at ₩24,000 for KOSDAQ debut
L&C BIO, a tissue engineering company, said on Friday that it has set its o...
by So Jae-hyeon  |  2018-10-22 14:12
라인
'Superbug' fears bring antibiotics developers under spotlight
Investors are paying keen attention to antibiotics developers amid growing ...
by Nam Doo-hyun  |  2018-10-22 11:53
라인
Celltrion, Samsung BioLogics named Fortune’s ‘Future 50’
Fortune, a U.S.-based multinational business magazine, has named Samsung Bi...
by Lee Han-soo  |  2018-10-19 16:34
라인
CancerRop launches unit to develop cell therapies
CancerRop established CancerRop Cell on Wednesday, a subsidiary to develop ...
by Lee Han-soo  |  2018-10-18 15:25
라인
Biogen, Samsung Bioepis announce European launch of Imraldi
Biogen and Samsung Bioepis said Tuesday they will launch Imraldi, the compa...
by Lee Han-soo  |  2018-10-17 17:28
여백
여백
여백
Back to Top